Arylidene analogues as selective COX-2 inhibitors: synthesis, characterization, <i>in silico</i> and <i>in vitro</i> studies
作者:Dipti L. Namera、Sampark S. Thakkar、Parth Thakor、Umed Bhoya、Anamik Shah
DOI:10.1080/07391102.2020.1806109
日期:2021.12.12
sulfonamide being pyrazole derivative COX-2 inhibitors, which used to treat pain and inflammation; they may also have a role in cancer prevention. In the present investigation, a series of arylidene analogues (NDP-4011 to NDP-4016) were synthesized by the condensation of 4-(3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl) benzenesulfonamide (I) with various substituted aromatic aldehydes in ethanol using a
摘要 已知吡唑衍生物作为非甾体抗炎药(NSAID)。塞来昔布是首创的磺胺类吡唑衍生物COX-2抑制剂,用于治疗疼痛和炎症;它们也可能在癌症预防中发挥作用。在本研究中,通过 4-(3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl) 缩合合成了一系列亚芳基类似物(NDP-4011到NDP-4016)苯磺酰胺 ( I ) 与各种取代的芳香醛在乙醇中使用催化量的哌啶。所有合成的化合物均通过 IR、1 H NMR、13C 核磁共振和质谱。在NRK-52E细胞系上测试合成化合物的细胞毒性。从中发现NDP-4011、NDP-4012、NDP-4013、NDP-1015和NDP-4016具有更高的细胞毒性,而与塞来昔布相比,NDP-4014的细胞毒性较低。的在计算机芯片上的化合物的药代动力学参数进行评估,以检查它们的候选资格作为药物。对 COX-2 结构进行分子对接,结